3-hydroxyanthranilate 3,4-Dioxygenase (HAAO) Peptide
-
- Target See all HAAO products
- HAAO (3-hydroxyanthranilate 3,4-Dioxygenase (HAAO))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- HRDVVIRQGE IFLLPARVPH SPQRFANTVG LVVERRRLET ELDGLRYYVG
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of HAAO antibody,
Alternative Names: HAAO control peptide, HAAO antibody Blocking Peptide, Anti-HAAO Blocking Peptide, 3-Hydroxyanthranilate 34-Dioxygenase Blocking Peptide, 3-HAO Blocking Peptide, HAO Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- HAAO (3-hydroxyanthranilate 3,4-Dioxygenase (HAAO))
- Synonyms
- Afu2g17450 Peptide, 0610007K21Rik Peptide, 0610012J07Rik Peptide, 3-HAO Peptide, 3-HAOxase Peptide, 3HAO Peptide, zgc:103585 Peptide, HAO Peptide, 3-hydroxyanthranilate 3,4-dioxygenase Peptide, 3-hydroxyanthranilate 3,4-dioxygenase L homeolog Peptide, SPO1774 Peptide, CNB05620 Peptide, AFUA_2G17450 Peptide, Bcep18194_C7641 Peptide, Kfla_5491 Peptide, Micau_4935 Peptide, RBRH_03005 Peptide, Krodi_1278 Peptide, haao Peptide, HAAO Peptide, Haao Peptide, haao.L Peptide
- Background
- 3-Hydroxyanthranilate 3,4-dioxygenase is a monomeric cytosolic protein belonging to the family of intramolecular dioxygenases containing nonheme ferrous iron. It is widely distributed in peripheral organs, such as liver and kidney, and is also present in low amounts in the central nervous system. HAAO catalyzes the synthesis of quinolinic acid (QUIN) from 3-hydroxyanthranilic acid. QUIN is an excitotoxin whose toxicity is mediated by its ability to activate glutamate N-methyl-D-aspartate receptors. Increased cerebral levels of QUIN may participate in the pathogenesis of neurologic and inflammatory disorders.
- Molecular Weight
- 32 kDa
-